美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA080197"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
23155-019-13 23155-019 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 20240630 ANDA ANDA080197 HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC. SULFASALAZINE 500 mg/1 300 TABLET in 1 BOTTLE (23155-019-13)
23155-019-10 23155-019 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 20240630 ANDA ANDA080197 HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC. SULFASALAZINE 500 mg/1 1000 TABLET in 1 BOTTLE (23155-019-10)
23155-019-05 23155-019 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 20240630 ANDA ANDA080197 HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC. SULFASALAZINE 500 mg/1 500 TABLET in 1 BOTTLE (23155-019-05)
23155-019-01 23155-019 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 20240630 ANDA ANDA080197 HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC. SULFASALAZINE 500 mg/1 100 TABLET in 1 BOTTLE (23155-019-01)
62135-960-01 62135-960 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 N/A ANDA ANDA080197 Chartwell RX, LLC. SULFASALAZINE 500 mg/1 100 TABLET in 1 BOTTLE (62135-960-01)
62135-960-05 62135-960 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 N/A ANDA ANDA080197 Chartwell RX, LLC. SULFASALAZINE 500 mg/1 500 TABLET in 1 BOTTLE (62135-960-05)
62135-960-10 62135-960 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 N/A ANDA ANDA080197 Chartwell RX, LLC. SULFASALAZINE 500 mg/1 1000 TABLET in 1 BOTTLE (62135-960-10)
62135-960-31 62135-960 HUMAN PRESCRIPTION DRUG Sulfasalazine Sulfasalazine TABLET ORAL 20210507 N/A ANDA ANDA080197 Chartwell RX, LLC. SULFASALAZINE 500 mg/1 300 TABLET in 1 BOTTLE (62135-960-31)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase